The Sterile Product Development group develops non-oral dosage forms—including injections, implants, inhaled products, and ocular products—for small, intermediate, and large molecules, from preclinical toxicology through commercialization. Its development teams establish robust formulation, packaging/device, process, and manufacturing strategies through scientific understanding and characterization, using experimental design, analytical tools, and predictive approaches to support product and process selection. The group enables translation of preclinical candidates into non-oral drug products. The Principal Scientist will serve as an Early-Stage Development and Commercialization Team (DCT) Leader for assigned pipeline biologics. The role provides strategic, technical, and operational direction to integrated CMC teams, progressing programs from candidate selection through early clinical development and First-in-Human milestones while laying groundwork for commercialization. The successful candidate brings biologics product development experience, supports relevant drug product activities, understands end-to-end CMC disciplines, and leads matrixed teams with a focus on robustness at launch. The DCT Leader is accountable for integrated CMC strategy, milestone readiness, cross-functional alignment, and progress through formal governance gates. The role also provides drug product leadership for early-stage work such as composition selection, scalable process development, packaging/device considerations, compatibility characterization, technology transfer, scale-up, and regulatory filing support. The position includes mentoring team members, supporting organizational strategy and innovation, and demonstrating inclusive leadership, sound judgment, adaptability, and strong communication skills.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Principal